“…Furthermore, the presence of surface VIM/vi-VIM is not restricted to infection with hepadnaviruses, as other viruses, such as human severe acute respiratory syndrome-related coronavirus (SARS-CoV), Japanese encephalitis virus (JEV), and enterovirus 71 (EV-A71), also induce this filamentous protein at least in vitro [ 23 , 63 , 64 , 65 ]. Surface VIM/vi-VIM is further used by SARS-CoV, JEV, EV-A71, porcine reproductive and respiratory syndrome virus, dengue virus, H9N2 subtype avian influenza virus, Chandipura virus, and cowpea mosaic virus as a receptor or at least as a co-receptor for cell attachment and entry by endocytosis, and in many studies viral infection can be reduced or even inhibited in vitro by using antibodies against VIM presented at the cell surface [ 62 , 64 , 66 , 67 , 68 , 69 , 70 , 71 ]. Although the exact mechanism of surface VIM/vi-VIM induction needs to be elucidated, infection with rather diverse viruses apparently changes the conformation of intracellular VIM thereby allowing its presentation on the cell surface.…”